Quest Partners LLC Purchases Shares of 4,796 Maximus, Inc. (NYSE:MMS)

Quest Partners LLC acquired a new stake in Maximus, Inc. (NYSE:MMS) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 4,796 shares of the health services provider’s stock, valued at approximately $402,000.

Several other hedge funds have also added to or reduced their stakes in MMS. Charles Schwab Investment Management Inc. boosted its position in shares of Maximus by 1.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 716,501 shares of the health services provider’s stock worth $60,086,000 after purchasing an additional 8,702 shares in the last quarter. Knights of Columbus Asset Advisors LLC lifted its stake in Maximus by 346.3% in the fourth quarter. Knights of Columbus Asset Advisors LLC now owns 118,290 shares of the health services provider’s stock worth $9,920,000 after purchasing an additional 91,788 shares during the last quarter. DekaBank Deutsche Girozentrale increased its position in shares of Maximus by 501.4% in the fourth quarter. DekaBank Deutsche Girozentrale now owns 42,100 shares of the health services provider’s stock valued at $3,511,000 after acquiring an additional 35,100 shares during the period. DAVENPORT & Co LLC purchased a new position in shares of Maximus in the fourth quarter valued at about $1,157,000. Finally, Legato Capital Management LLC increased its position in shares of Maximus by 134.1% during the fourth quarter. Legato Capital Management LLC now owns 23,521 shares of the health services provider’s stock valued at $1,972,000 after buying an additional 13,474 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Down 0.2 %

Maximus stock traded down $0.16 during trading on Friday, reaching $85.96. The stock had a trading volume of 249,716 shares, compared to its average volume of 356,899. The business has a 50 day moving average price of $82.74 and a 200 day moving average price of $82.48. The stock has a market cap of $5.23 billion, a PE ratio of 22.56 and a beta of 0.72. Maximus, Inc. has a 52-week low of $72.39 and a 52-week high of $90.65. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.63.

Maximus (NYSE:MMS) last released its quarterly earnings data on Wednesday, May 8th. The health services provider reported $1.57 EPS for the quarter, topping the consensus estimate of $1.31 by $0.26. Maximus had a net margin of 4.58% and a return on equity of 18.02%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period in the previous year, the firm earned $0.80 EPS. The business’s revenue for the quarter was up 11.7% compared to the same quarter last year. On average, analysts predict that Maximus, Inc. will post 5.85 EPS for the current year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus’s dividend payout ratio (DPR) is 31.50%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.